Activity in this selectionnds-corporation-d2b6db09
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $60M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionBreezeBioDevelops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues
Role not disclosed